Synonyms: BMS 907351; BMS-907351; cabozantinib (S)-malate; Cabozantinib malate; Cabozantinib malate (XL184); Cabometyx; Cabozantinib (S-malate); Cabozantinib L-Malate Salt; UNII-DR7ST46X58; Cometriq; Cabozantinib s-malate [USAN]; DR7ST46X58; BMS907351; BMS907351; CHEBI:72319; Cometriq (TN); Cabozantinib s-malate (USAN); (2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1); cabozantinib-malate; cabozantinib L-malate; Cabozantinib malate (JAN); XL184(Cabozantinib malate); MLS006010951; cabozantinib; CHEMBL2103868; HFCFMRYTXDINDK-WNQIDUERSA-N; C28H24FN3O5.C4H6O5; KS-00000LA2; 2296AH; MFCD20923480; s4001; AKOS025401945; CS-0201; SB17293; Cometriq; AC-27471; HY-12044; SC-91041; SMR004702755; SW218093-2; D10095; W-5841; (2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(; (2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluor; (2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; XL 184; (2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1); 1,1-Cyclopropanedicarboxamide, N'-(4-((6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4- fluorophenyl)- mono((2S)-2-hydroxybutanedioate); Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1); cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide(4-fluoro-phenyl)-amide, (S) malate salt; N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-hydroxysuccinate; N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-hydroxysuccinate; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (2S)-2-Hydroxybutanedioic Acid; N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (2S)-2-hydroxybutanedioate; XL184; XL 184; XL-184; XL-184; BMS 907351; 1140909-48-3 (malate salt); B1401; Cabozantinib malate, 98%, a potent VEGFR2 inhibitor - 10MG 10mg; 849217-68-1; XL184 cpd; 1140909-48-3; Cabozantinib S-malate;